Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.02
PBH's Cash-to-Debt is ranked lower than
96% of the 53 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.74 vs. PBH: 0.02 )
Ranked among companies with meaningful Cash-to-Debt only.
PBH' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.02 Max: No Debt
Current: 0.02
Equity-to-Asset 0.21
PBH's Equity-to-Asset is ranked lower than
73% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.42 vs. PBH: 0.21 )
Ranked among companies with meaningful Equity-to-Asset only.
PBH' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.21  Med: 0.34 Max: 0.46
Current: 0.21
0.21
0.46
Interest Coverage 2.20
PBH's Interest Coverage is ranked lower than
91% of the 45 Companies
in the Global Medical Distribution industry.

( Industry Median: 13.37 vs. PBH: 2.20 )
Ranked among companies with meaningful Interest Coverage only.
PBH' s Interest Coverage Range Over the Past 10 Years
Min: 2.2  Med: 2.55 Max: 3.41
Current: 2.2
2.2
3.41
Piotroski F-Score: 3
Altman Z-Score: 1.10
Beneish M-Score: -2.12
WACC vs ROIC
6.44%
5.33%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 23.31
PBH's Operating Margin % is ranked higher than
96% of the 53 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.78 vs. PBH: 23.31 )
Ranked among companies with meaningful Operating Margin % only.
PBH' s Operating Margin % Range Over the Past 10 Years
Min: -55.89  Med: 27.38 Max: 32.29
Current: 23.31
-55.89
32.29
Net Margin % 7.87
PBH's Net Margin % is ranked higher than
85% of the 53 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.65 vs. PBH: 7.87 )
Ranked among companies with meaningful Net Margin % only.
PBH' s Net Margin % Range Over the Past 10 Years
Min: -61.61  Med: 10.48 Max: 12.39
Current: 7.87
-61.61
12.39
ROE % 8.95
PBH's ROE % is ranked lower than
55% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.33 vs. PBH: 8.95 )
Ranked among companies with meaningful ROE % only.
PBH' s ROE % Range Over the Past 10 Years
Min: -48.3  Med: 10.02 Max: 14.88
Current: 8.95
-48.3
14.88
ROA % 2.26
PBH's ROA % is ranked lower than
64% of the 53 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.93 vs. PBH: 2.26 )
Ranked among companies with meaningful ROA % only.
PBH' s ROA % Range Over the Past 10 Years
Min: -20.19  Med: 3.37 Max: 4.11
Current: 2.26
-20.19
4.11
ROC (Joel Greenblatt) % 138.80
PBH's ROC (Joel Greenblatt) % is ranked higher than
92% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 22.27 vs. PBH: 138.80 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
PBH' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -396.15  Med: 203.33 Max: 299.62
Current: 138.8
-396.15
299.62
3-Year Revenue Growth Rate 13.10
PBH's 3-Year Revenue Growth Rate is ranked higher than
55% of the 44 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.40 vs. PBH: 13.10 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
PBH' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: 12.9 Max: 84.2
Current: 13.1
0
84.2
3-Year EBITDA Growth Rate 7.10
PBH's 3-Year EBITDA Growth Rate is ranked lower than
54% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.40 vs. PBH: 7.10 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
PBH' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 16.3 Max: 59.3
Current: 7.1
0
59.3
3-Year EPS without NRI Growth Rate -2.20
PBH's 3-Year EPS without NRI Growth Rate is ranked lower than
53% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.30 vs. PBH: -2.20 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
PBH' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 14 Max: 263.4
Current: -2.2
0
263.4
GuruFocus has detected 3 Warning Signs with Prestige Brands Holdings Inc $PBH.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» PBH's 30-Y Financials

Financials (Next Earnings Date: 2017-08-11 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q2 2016

PBH Guru Trades in Q2 2016

Ken Fisher 1,469,502 sh (unchged)
Murray Stahl 20,265 sh (-0.45%)
Joel Greenblatt 17,679 sh (-6.17%)
Jim Simons 480,800 sh (-11.84%)
Paul Tudor Jones 7,100 sh (-52.55%)
» More
Q3 2016

PBH Guru Trades in Q3 2016

Joel Greenblatt 52,589 sh (+197.47%)
Jim Simons 680,100 sh (+41.45%)
Paul Tudor Jones 7,400 sh (+4.23%)
Ken Fisher 1,519,258 sh (+3.39%)
Murray Stahl 15,150 sh (-25.24%)
» More
Q4 2016

PBH Guru Trades in Q4 2016

Joel Greenblatt 129,271 sh (+145.81%)
Murray Stahl Sold Out
Ken Fisher 1,509,216 sh (-0.66%)
Paul Tudor Jones 6,100 sh (-17.57%)
Jim Simons 391,500 sh (-42.43%)
» More
Q1 2017

PBH Guru Trades in Q1 2017

Robert Olstein 33,330 sh (New)
Jim Simons 486,000 sh (+24.14%)
Paul Tudor Jones 6,700 sh (+9.84%)
Ken Fisher 1,499,958 sh (-0.61%)
Joel Greenblatt 126,076 sh (-2.47%)
» More
» Details

Insider Trades

Latest Guru Trades with PBH

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Distribution » Medical Distribution    NAICS: 325412    SIC: 2834
Compare:NYSE:OMI, NAS:PDCO, NYSE:PMC, OTCPK:SNYR, OTCPK:FZMD, OTCPK:SCVM, OTCPK:SHPMY, OTCPK:SHTDF, NAS:HSIC, NYSE:ABC, NYSE:CAH, NYSE:MCK » details
Traded in other countries:PBV.Germany,
Headquarter Location:USA
Prestige Brands Holdings Inc is engaged in the marketing, sales and distribution of well-recognized, brand name OTC healthcare and household cleaning products to mass merchandisers, drug stores, supermarkets, and club, convenience, and dollar stores.

Prestige Brands distributes branded over-the-counter healthcare and household cleaning products to mass merchandisers, drug stores, convenience stores, and supermarkets. The firm's major brands include Chloraseptic, Clear Eyes, Compound W, Dramamine, and Comet. Prestige Brands operates in three segments: North American over-the-counter, or OTC, healthcare; international over-the-counter healthcare; and household cleaning. The North American OTC segment generates the vast majority of revenue. The largest product groups in the OTC healthcare segments include analgesics, cough and cold, gastrointestinal, and women's health. Prestige Brands has customers in the United States, Canada, and Australia. Sales within the United States contribute the majority of revenue.

Guru Investment Theses on Prestige Brands Holdings Inc

Wallace Weitz Comments on Prestige Brands Holdings - Nov 06, 2015

Prestige Brands Holdings is engaged in the marketing, sales and distribution of brand name, over-the-counter healthcare and household cleaning products to mass merchandisers and drug stores in North America, Australia and other international markets. Prestige’s stock has appreciated due to an improved outlook for their consumer health products and the Company’s recent acquisition of the Monistat brand which appears on track to deliver additional future growth. We eliminated the position in the third quarter when the stock price reached our business value estimate.

From Wallace Weitz (Trades, Portfolio)'s Hickory Fund commentary for third quarter 2015.

Check out Wallace Weitz latest stock trades

Ratios

vs
industry
vs
history
PE Ratio 38.54
PBH's PE Ratio is ranked lower than
83% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 19.66 vs. PBH: 38.54 )
Ranked among companies with meaningful PE Ratio only.
PBH' s PE Ratio Range Over the Past 10 Years
Min: 7.81  Med: 20.22 Max: 44.3
Current: 38.54
7.81
44.3
Forward PE Ratio 18.35
PBH's Forward PE Ratio is ranked lower than
79% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.08 vs. PBH: 18.35 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 38.54
PBH's PE Ratio without NRI is ranked lower than
83% of the 42 Companies
in the Global Medical Distribution industry.

( Industry Median: 20.98 vs. PBH: 38.54 )
Ranked among companies with meaningful PE Ratio without NRI only.
PBH' s PE Ratio without NRI Range Over the Past 10 Years
Min: 7.93  Med: 19.98 Max: 44.3
Current: 38.54
7.93
44.3
Price-to-Owner-Earnings 37.55
PBH's Price-to-Owner-Earnings is ranked lower than
99.99% of the 29 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.77 vs. PBH: 37.55 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
PBH' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.08  Med: 10.39 Max: 1197.3
Current: 37.55
5.08
1197.3
PB Ratio 3.28
PBH's PB Ratio is ranked lower than
69% of the 52 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.47 vs. PBH: 3.28 )
Ranked among companies with meaningful PB Ratio only.
PBH' s PB Ratio Range Over the Past 10 Years
Min: 0.54  Med: 1.68 Max: 4.17
Current: 3.28
0.54
4.17
PS Ratio 3.05
PBH's PS Ratio is ranked lower than
84% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.13 vs. PBH: 3.05 )
Ranked among companies with meaningful PS Ratio only.
PBH' s PS Ratio Range Over the Past 10 Years
Min: 0.67  Med: 1.85 Max: 3.74
Current: 3.05
0.67
3.74
Price-to-Free-Cash-Flow 18.39
PBH's Price-to-Free-Cash-Flow is ranked lower than
55% of the 22 Companies
in the Global Medical Distribution industry.

( Industry Median: 16.56 vs. PBH: 18.39 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
PBH' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 3.12  Med: 11.02 Max: 21.16
Current: 18.39
3.12
21.16
Price-to-Operating-Cash-Flow 18.01
PBH's Price-to-Operating-Cash-Flow is ranked lower than
70% of the 23 Companies
in the Global Medical Distribution industry.

( Industry Median: 12.03 vs. PBH: 18.01 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
PBH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.1  Med: 9.66 Max: 20.72
Current: 18.01
3.1
20.72
EV-to-EBIT 23.50
PBH's EV-to-EBIT is ranked lower than
78% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.81 vs. PBH: 23.50 )
Ranked among companies with meaningful EV-to-EBIT only.
PBH' s EV-to-EBIT Range Over the Past 10 Years
Min: -4.3  Med: 12.7 Max: 25.6
Current: 23.5
-4.3
25.6
EV-to-EBITDA 20.87
PBH's EV-to-EBITDA is ranked lower than
88% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.78 vs. PBH: 20.87 )
Ranked among companies with meaningful EV-to-EBITDA only.
PBH' s EV-to-EBITDA Range Over the Past 10 Years
Min: -4.6  Med: 11.7 Max: 22.7
Current: 20.87
-4.6
22.7
PEG Ratio 2.97
PBH's PEG Ratio is ranked higher than
67% of the 27 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.00 vs. PBH: 2.97 )
Ranked among companies with meaningful PEG Ratio only.
PBH' s PEG Ratio Range Over the Past 10 Years
Min: 0.95  Med: 1.31 Max: 3.93
Current: 2.97
0.95
3.93
Shiller PE Ratio 78.55
PBH's Shiller PE Ratio is ranked lower than
94% of the 18 Companies
in the Global Medical Distribution industry.

( Industry Median: 30.82 vs. PBH: 78.55 )
Ranked among companies with meaningful Shiller PE Ratio only.
PBH' s Shiller PE Ratio Range Over the Past 10 Years
Min: 72.44  Med: 97.82 Max: 219.63
Current: 78.55
72.44
219.63
Current Ratio 2.06
PBH's Current Ratio is ranked higher than
67% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.62 vs. PBH: 2.06 )
Ranked among companies with meaningful Current Ratio only.
PBH' s Current Ratio Range Over the Past 10 Years
Min: 1.7  Med: 2.08 Max: 3.03
Current: 2.06
1.7
3.03
Quick Ratio 1.35
PBH's Quick Ratio is ranked higher than
61% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.07 vs. PBH: 1.35 )
Ranked among companies with meaningful Quick Ratio only.
PBH' s Quick Ratio Range Over the Past 10 Years
Min: 1.08  Med: 1.4 Max: 2.27
Current: 1.35
1.08
2.27
Days Inventory 95.34
PBH's Days Inventory is ranked lower than
78% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 41.10 vs. PBH: 95.34 )
Ranked among companies with meaningful Days Inventory only.
PBH' s Days Inventory Range Over the Past 10 Years
Min: 69.11  Med: 75.95 Max: 98.89
Current: 95.34
69.11
98.89
Days Sales Outstanding 56.00
PBH's Days Sales Outstanding is ranked higher than
56% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 53.92 vs. PBH: 56.00 )
Ranked among companies with meaningful Days Sales Outstanding only.
PBH' s Days Sales Outstanding Range Over the Past 10 Years
Min: 38.2  Med: 43.53 Max: 56
Current: 56
38.2
56
Days Payable 67.13
PBH's Days Payable is ranked lower than
68% of the 40 Companies
in the Global Medical Distribution industry.

( Industry Median: 65.77 vs. PBH: 67.13 )
Ranked among companies with meaningful Days Payable only.
PBH' s Days Payable Range Over the Past 10 Years
Min: 33.5  Med: 47.53 Max: 67.85
Current: 67.13
33.5
67.85

Buy Back

vs
industry
vs
history
3-Year Dividend Growth Rate -100.00
PBH's 3-Year Dividend Growth Rate is ranked lower than
99.99% of the 25 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.50 vs. PBH: -100.00 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
PBH' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: -100
Current: -100
5-Year Yield-on-Cost % 0.75
PBH's 5-Year Yield-on-Cost % is ranked lower than
98% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 4.58 vs. PBH: 0.75 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
PBH' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.75  Med: 0.95 Max: 1.18
Current: 0.75
0.75
1.18
3-Year Average Share Buyback Ratio -1.00
PBH's 3-Year Average Share Buyback Ratio is ranked higher than
57% of the 35 Companies
in the Global Medical Distribution industry.

( Industry Median: -1.40 vs. PBH: -1.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
PBH' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -23.5  Med: -0.45 Max: 0
Current: -1
-23.5
0

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 2.89
PBH's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
74% of the 27 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.59 vs. PBH: 2.89 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
PBH' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0  Med: 2.34 Max: 14.81
Current: 2.89
0
14.81
Price-to-Median-PS-Value 1.62
PBH's Price-to-Median-PS-Value is ranked lower than
90% of the 39 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.01 vs. PBH: 1.62 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
PBH' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0  Med: 1.1 Max: 1.9
Current: 1.62
0
1.9
Price-to-Peter-Lynch-Fair-Value 3.39
PBH's Price-to-Peter-Lynch-Fair-Value is ranked lower than
85% of the 13 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.01 vs. PBH: 3.39 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
PBH' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0  Med: 1.29 Max: 3.5
Current: 3.39
0
3.5
Earnings Yield (Greenblatt) % 4.24
PBH's Earnings Yield (Greenblatt) % is ranked lower than
78% of the 58 Companies
in the Global Medical Distribution industry.

( Industry Median: 6.75 vs. PBH: 4.24 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
PBH' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 3.9  Med: 7.5 Max: 13.7
Current: 4.24
3.9
13.7
Forward Rate of Return (Yacktman) % 11.57
PBH's Forward Rate of Return (Yacktman) % is ranked higher than
62% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.60 vs. PBH: 11.57 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
PBH' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 4.6  Med: 12.1 Max: 29.2
Current: 11.57
4.6
29.2

More Statistics

Revenue (TTM) (Mil) $882.1
EPS (TTM) $ 1.30
Beta1.11
Short Percentage of Float4.56%
52-Week Range $44.64 - 59.63
Shares Outstanding (Mil)52.96

Analyst Estimate

Mar18 Mar19 Mar20
Revenue (Mil $) 1,066 1,091 1,176
EPS ($) 2.73 2.98 3.45
EPS without NRI ($) 2.73 2.98 3.45
EPS Growth Rate
(Future 3Y To 5Y Estimate)
10.30%
Dividends per Share ($)
» More Articles for PBH

Headlines

Articles On GuruFocus.com
Wallace Weitz Comments on Prestige Brands Holdings Nov 06 2015 
Earnings Upward Reaction: Prestige Brands Holdings (PBH), Proto Labs (PRLB) Feb 05 2015 
Meridian Funds Comments on Prestige Brands Sep 08 2014 
Meridian Growth Fund Second Quarter 2014 Commentary Sep 08 2014 
Paulson Bets Again On Mallinckrodt Aug 07 2014 
Private Capital Management Sells Update Nov 27 2013 
Gold Guru John Paulson Drops Gold ABX in First Quarter Sells May 18 2013 
Weekly CEO Sells Highlight: Smiths News, Prestige Brands Holdings, Proto Labs, Imax Corp Nov 26 2012 
Why I'd Never Pay More Than Book Value for Nokia (NOK) Apr 12 2012 
Prestige Brands Holdings Inc. Reports Operating Results (10-Q) Feb 09 2011 

More From Other Websites
Prestige Brands Holdings, Inc. :PBH-US: Earnings Analysis: 2017 By the Numbers : May 18, 2017 May 18 2017
Edited Transcript of PBH earnings conference call or presentation 11-May-17 12:30pm GMT May 17 2017
Prestige Brands misses 4Q profit forecasts May 11 2017
Prestige Brands Holdings, Inc. Reports Fiscal 2017 Fourth Quarter and Full Year Results; Provides... May 11 2017
Prestige Brands Holdings, Inc. breached its 50 day moving average in a Bullish Manner : PBH-US : May... May 10 2017
Prestige Brands Holdings, Inc. – Value Analysis (NYSE:PBH) : April 27, 2017 Apr 27 2017
Prestige Brands Holdings, Inc. breached its 50 day moving average in a Bullish Manner : PBH-US :... Apr 26 2017
Prestige Brands Holdings, Inc. to Release Fiscal 2017 Fourth Quarter and Year-End Earnings Results Apr 11 2017
Prestige Brands Holdings, Inc. breached its 50 day moving average in a Bearish Manner : PBH-US :... Apr 03 2017
5 Reasons to Add SodaStream (SODA) to Your Portfolio Now Mar 16 2017
Prestige Brands Holdings (PBH): Moving Average Crossover Alert Feb 13 2017
Prestige Brands Holdings, Inc. :PBH-US: Earnings Analysis: Q3, 2017 By the Numbers : February 7,... Feb 07 2017
Edited Transcript of PBH earnings conference call or presentation 2-Feb-17 1:30pm GMT Feb 02 2017
Prestige Brands tops Street 3Q forecasts Feb 02 2017
Prestige Brands Holdings, Inc. Reports Third Quarter Fiscal 2017 Results Feb 02 2017
Why DryShips Stock Dropped Another 18% Today Jan 24 2017
Prestige Brands, Inc. -- Moody's confirms Prestige Brands' B2 CFR following announcement of CB Fleet... Jan 11 2017
Prestige Brands Holdings, Inc. to Release Fiscal 2017 Third Quarter Earnings on February 2nd Jan 06 2017
NFI Consumer Healthcare Completes Acquisition of OTC Brand e.p.t® from Prestige Brands Holdings,... Dec 29 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat